HIT Consultant August 23, 2024
Syed Hamza Sohail

What You Should Know:

Falfurrias Management Partners (Falfurrias), a Charlotte-based private equity firm focused on growth-oriented, middle-market businesses, today announced its investment in Jumo Health, an innovative and award-winning clinical trial solutions company driving better outcomes for clinical trials globally.

Jumo Health develops creative, patient-centric educational solutions that improve health literacy to accelerate clinical trial enrollment and increase participant retention.

Falfurrias Capital Partners Invests in Jumo Health to Enhance Clinical Trial Engagement and Diversity

Falfurrias Capital Partners has announced an investment in Jumo Health, aiming to address critical challenges in clinical trials, such as low enrollment, high dropout rates, and the lack of diverse representation. This strategic investment will bring new resources and expertise to Jumo Health, enhancing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Investments, Trends
Text messages can be ineffective as medication refill reminders
Challenges and Opportunities for Digital Innovation in Clinical Trials
AI Teaches Surgery; AI Quality Registry; AI Matches Patients With Trials
New NIH tool uses genAI to connect volunteers with clinical trials
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article